Edition:
United States

MDxHealth SA (MDXH.BR)

MDXH.BR on Brussels Stock Exchange

4.72EUR
9:36am EDT
Change (% chg)

€-0.03 (-0.57%)
Prev Close
€4.75
Open
€4.75
Day's High
€4.76
Day's Low
€4.72
Volume
37,285
Avg. Vol
150,467
52-wk High
€5.78
52-wk Low
€3.20

Select another date:

Mon, Jul 10 2017

BRIEF-MDxHealth announces distribution agreement with IPS Genomix

* REG-SELECTMDX TO BE DISTRIBUTED ACROSS MIDDLE EAST BY IPS GENOMIX Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-MDxHealth launches AssureMDx for bladder cancer liquid biopsy test

* REG-MDXHEALTH LAUNCHES ASSUREMDX FOR BLADDER CANCER LIQUID BIOPSY TEST Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-MDxHealth announces results identifying lack of knowledge on new generation biomarker tests for prostate cancer

* ANNOUNCES RESULTS FROM AN INDEPENDENT SURVEY IDENTIFY LACK OF KNOWLEDGE ON NEW GENERATION BIOMARKER TESTS FOR PROSTATE CANCER Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-MDxHealth and Queensland University of Technology collaborate on oral cancer liquid biopsy test

* REG-MDXHEALTH AND QUEENSLAND UNIVERSITY OF TECHNOLOGY COLLABORATE ON ORAL CANCER LIQUID BIOPSY TEST

BRIEF-MdxHealth Q1 revenue growth of 128%, or $19.4 million

* Q1 SHARP REVENUE GROWTH OF 128%, OR $19.4 MILLION, COMPARED TO THE SAME PERIOD IN 2016

BRIEF-MDxHealth and Maastricht University collaborate on (EPI)genetic cancer diagnostics

* Mdxhealth and maastricht university collaborate on next generation (EPI)genetic cancer diagnostics

BRIEF-MDxhealth announces new contract with MediNcrease Health Plans regarding ConfirmMDx and SelectMDx

* Reg-MDxhealth announces new contract with MediNcrease Health Plans regarding ConfirmMDx and SelectMDx Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Mdxhealth and Exact Sciences sign collaboration agreement

* Mdxhealth and Exact Sciences sign collaboration agreement for collaboration in the growing field of epigenetics and molecular diagnostics

BRIEF-Mdxhealth announces cost-effective results for its SelectMDx test for biopsy selection

* New study shows MDxHealth's SelectMDx test is cost-effective for biopsy selection

BRIEF-Mdxhealth signs an exclusive licensing deal with Ghent University in Belgium

* Signed an exclusive licensing deal with Ghent University in Belgium

Select another date: